Some of thermo-responsive polysaccharides, namely, cellulose, xyloglucan, and chitosan,
and protein-like gelatin or elastin-like polypeptides can exhibit temperature dependent sol …

Mucosal administration especially via the nasal route is a novel and promising technique for
medication and vaccine delivery. Mucosal pathways provide notable benefits that promote …

Rotigotine (RTG) is a non-ergoline dopamine agonist and an approved drug for treating
Parkinson's disease. However, its clinical use is limited due to various problems, viz. poor …

In the current work, triamcinolone acetonide (TAA) loaded dual responsive in situ gelling
system was designed and optimized using reacted tamarind seed xyloglucan (RXG) …

Rotigotine (RTG) is an anti-Parkinson's drug approved by the USFDA to treat motor and non-
motor symptoms of both early and advanced stages of the disease. However, issues like …

Background Polysaccharides acceded by the Food and Drug Administration are among the
most exploitable polymers for fabricating nasally applied vehicles containing therapeutically …

Drug absorption is improved by the intranasal route's wide surface area and avoidance of
first-pass metabolism. For the treatment of central nervous system diseases such as …

In the last years, neurological diseases have resulted in a global health issue, representing
the first cause of disability worldwide. Current therapeutic approaches against neurological …

Rufinamide (Rufi) is an antiepileptic drug used to manage Lennox-Gastaut Syndrome and
partial seizures. The oral bioavailability of Rufi is less due to its poor solubility and low …

In 2004, the US FDA approved Rufinamide, an anti-epileptic drug under the brand name
Banzel®. In 2015, Banzel® received approval for its use in pediatric patients (ages 1–4 …